Systemic Lupus Erythematosus-related Lung Disease

Area of Science:

• Rheumatology
• Pulmonology
• Autoimmune Diseases

Background:

• Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease affecting multiple organ systems.
• Pulmonary manifestations are a major cause of morbidity and mortality in SLE patients.
• A wide spectrum of lung diseases can occur in SLE, ranging from airway to parenchymal and vascular conditions.

Purpose of the Study:

• To provide a comprehensive overview of pulmonary diseases associated with SLE.
• To discuss diagnostic approaches and treatment strategies for these manifestations.
• To highlight the need for evidence-based guidelines to improve patient outcomes.

Main Methods:

• This is a comprehensive review of the literature on pulmonary involvement in SLE.
• The review categorizes pulmonary manifestations into upper airway, lower airway, parenchymal, pleural, and vascular diseases.
• Diagnostic modalities, treatment options, and prognosis are discussed for each category.

Main Results:

• Pulmonary involvement in SLE encompasses a broad range of conditions including interstitial lung disease, diffuse alveolar hemorrhage, pulmonary arterial hypertension, and shrinking lung syndrome.
• Diagnostic challenges persist, and standardized treatment guidelines are currently lacking.
• Effective management requires a thorough understanding of the diverse pulmonary manifestations and their specific treatments.

Conclusions:

• Pulmonary disease is a critical and often under-recognized aspect of SLE.
• Improved diagnostic tools and evidence-based treatment guidelines are essential for optimizing care and prognosis in SLE patients with lung involvement.
• Further research is needed to establish standardized management protocols.